carfilzomib Injection [Kyprolis]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background Carfilzomib (Kyprolis®) is a second-generation, selective and irreversible proteasome inhibitor. Profound knowledge…
Introduction Carfilzomib (Kyprolis™) is a second-generation proteasome inhibitor for the treatment of relapsing multiple myeloma…
lenalidomide and dexamethasone) for the treatment of adult patients with multiple myeloma who have received at least one prior…
espanolSe resenan los medicamentos evaluados y con dictamen positivo por comision de expertos de la Agencia Espanola de…
The initial enthusiasm following the discovery of a pharmacologically active natural product is often fleeting due to the poor…